載入...
Suvorexant: The first orexin receptor antagonist to treat insomnia
Primary insomnia is mainly treated with drugs acting on benzodiazepine receptors and a few other classes of drugs used for different co-morbidities. A novel approach to treat insomnia has been introduced recently, with the approval of suvorexant, the first in a new class of orexin receptor antagonis...
Na minha lista:
| 發表在: | J Pharmacol Pharmacother |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Medknow Publications & Media Pvt Ltd
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4419247/ https://ncbi.nlm.nih.gov/pubmed/25969666 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0976-500X.155496 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|